Use of K-Ras as a predictive biomarker for selecting anti-EGF receptor/pathway treatment (Q37779308)

23 August 2017

1 reference

title

Use of K-Ras as a predictive biomarker for selecting anti-EGF receptor/pathway treatment (English)

1 reference

23 August 2017

0 references

4

Jaffer A Ajani

1 reference

23 August 2017

2

Heath Mackley

1 reference

23 August 2017

Yixing Jiang

1

1 reference

PubMed ID

20701442

23 August 2017

Hua Cheng

series ordinal

3

1 reference

23 August 2017

1 August 2010

1 reference

23 August 2017

Biomarkers in Medicine

1 reference

23 August 2017

4

1 reference

23 August 2017

4

1 reference

23 August 2017

535-541

1 reference

Detection of high incidence of K-ras oncogenes during human colon tumorigenesis

23 August 2017

1 reference

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

21 January 2018

1 reference

EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma.

21 January 2018

1 reference

The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer.

21 January 2018

1 reference

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

The multidisciplinary management of gastrointestinal cancer. The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer

21 January 2018

1 reference

KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

21 January 2018

1 reference

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

21 January 2018

1 reference

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens?

21 January 2018

1 reference

Restoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors

21 January 2018

1 reference

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers.

21 January 2018

1 reference

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.

21 January 2018

1 reference

Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099.

21 January 2018

1 reference

Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer

21 January 2018

1 reference

Erlotinib in previously treated non-small-cell lung cancer

21 January 2018

1 reference

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): study of a comprehensive panel of molecular markers.

21 January 2018

1 reference

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer

21 January 2018

1 reference

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.

21 January 2018

1 reference

Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab

21 January 2018

1 reference

Targeting RAS signalling pathways in cancer therapy

21 January 2018

1 reference

21 January 2018

1 reference

Prevalence of ras gene mutations in human colorectal cancers

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/BMM.10.74

1 reference

23 August 2017

1 reference

PubMed ID

20701442